Fig. 7: Proposed mechanism of FOXD2-AS1-mediated STAT3 activation in LSCC.

Upregulated FOXD2-AS1 promoted transcriptional activity of STAT3, by serving as scaffold of STAT3 and PRMT5, and subsequently conferred the cancer stemness and chemoresistance in LSCC.